Download PDF
Int J Sports Med 2013; 34(03): 274-280
DOI: 10.1055/s-0032-1316365
Genetics & Molecular Biology
© Georg Thieme Verlag KG Stuttgart · New York

GNAS A-1121G Variant is Associated with Improved Diastolic Dysfunction in Response to Exercise Training in Heart Failure Patients

A. J. Alves
1   Faculty of Sport, Research Centre in Physical Activity, Health and Leisure, University of Porto, Porto, Portugal
,
E. Goldhammer
2   Bnai-Zion Haifa Medical Center, Heart Institute, Haifa, Israel
,
F. Ribeiro
1   Faculty of Sport, Research Centre in Physical Activity, Health and Leisure, University of Porto, Porto, Portugal
6   CESPU, Polytechnic Health Institute of the North, Physiotherapy Department Gandra PRD
,
N. Eynon
3   Institute of Sports Exercise and Active Living, Victoria University, Melbourne, Australia
,
S. Ben-Zaken Cohen
4   Genetics and Molecular Biology Laboratory, The Zinman College of Physical Education and Sport Sciences at the Wingate Institute, Netanya, United States
,
J. A. Duarte
1   Faculty of Sport, Research Centre in Physical Activity, Health and Leisure, University of Porto, Porto, Portugal
,
J. L. Viana
5   School of Sport, Exercise and Health Sciences Loughborough, Loughborough University, United Kingdom
7   Research Center in Sports, Health Sciences and Human Development (CIDESD), Portugal
,
M. Sagiv
4   Genetics and Molecular Biology Laboratory, The Zinman College of Physical Education and Sport Sciences at the Wingate Institute, Netanya, United States
,
J. Oliveira
1   Faculty of Sport, Research Centre in Physical Activity, Health and Leisure, University of Porto, Porto, Portugal
› Author Affiliations
Further Information

Publication History



accepted after revision 22 May 2012

Publication Date:
12 October 2012 (online)

Also available at
    Permissions and Reprints

Abstract

β1-adrenergic receptors (ADRB1) and Gαs proteins (GNAS) play important roles in the regulation of cardiac function. The present study sought to investigate whether ADRB1 Arg389Gly (rs1801253), GNAS -1211 G/A (rs6123837) and GNAS 2291 C/T (rs6026584) variants are associated with left ventricular function and exercise tolerance in heart failure patients. 61 heart failure patients completed a 6-month exercise-training programme. Left ventricular ejection fraction (LVEF), mitral inflow velocities (deceleration time, and E/A ratio) and exercise tolerance (METs) were assessed at baseline and following exercise training. There were no associations between the studied variants and LVEF or E/A ratio measured at baseline and after exercise training. Deceleration time of early mitral flow was higher at baseline in GNAS -1211G allele carriers compared with -1211A allele homozygotes (P<0.05). Exercise training attenuated deceleration time in -1211G allele carriers (P<0.05) but not in -1211A allele homozygotes. Moreover, ADRB1 389Gly homozygotes had a greater training-induced increase in exercise tolerance than 389Arg homozygotes (P=0.04). This study shows that the functional GNAS -1121 G/A polymorphism is associated with diastolic function at baseline and in response to exercise training in heart failure patients. Furthermore, our data suggest that ADRB1 Arg389Gly polymorphism may influence exercise tolerance.

Key words

exercise - polymorphism - heart failure
 

  • References

  • 1 Alves AJ, Eynon N, Oliveira J, Goldhammer E. Raas and adrenergic genes in heart failure: Function, predisposition and survival implications. World J Cardiol 2010; 2: 187-197
    CrossrefPubMedGoogle Scholar
  • 2 Alves AJ, Ribeiro F, Goldhammer E, Rivlin Y, Rosenschein U, Viana JL, Duarte JA, Sagiv M, Oliveira J. Exercise training improves diastolic function in heart failure patients. Med Sci Sports Exerc 2012; 44: 776-785
    PubMedGoogle Scholar
  • 3 American College of Sports Medicine . ACSM’s guidelines for Exercise Testing and Prescription. Baltimore: Lippincott Williams & Wilkins; 2006
    Google Scholar
  • 4 Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment. Eur Heart J 2011; 32: 670-679
    CrossrefPubMedGoogle Scholar
  • 5 Bray MS, Hagberg JM, Perusse L, Rankinen T, Roth SM, Wolfarth B, Bouchard C. The human gene map for performance and health-related fitness phenotypes: The 2006–2007 update. Med Sci Sports Exerc 2009; 41: 35-73
    PubMedGoogle Scholar
  • 6 Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982; 307: 205-211
    CrossrefPubMedGoogle Scholar
  • 7 Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986; 59: 297-309
    CrossrefPubMedGoogle Scholar
  • 8 Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T, Brodde OE. The arg389gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J Am Coll Cardiol 2005; 46: 2111-2115
    CrossrefPubMedGoogle Scholar
  • 9 Buscher R, Belger H, Eilmes KJ, Tellkamp R, Radke J, Dhein S, Hoyer PF, Michel MC, Insel PA, Brodde OE. In-vivo studies do not support a major functional role for the gly389arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics 2001; 11: 199-205
    CrossrefPubMedGoogle Scholar
  • 10 Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni Jr JF, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM, Collins FS. Replicating genotype-phenotype associations. Nature 2007; 447: 655-660
    CrossrefPubMedGoogle Scholar
  • 11 Coats AJ, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi L, Solda PL, Davey P, Ormerod O, Forfar C. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85: 2119-2131
    CrossrefPubMedGoogle Scholar
  • 12 Crimi E, Ignarro LJ, Cacciatore F, Napoli C. Mechanisms by which exercise training benefits patients with heart failure. Nat Rev Cardiol 2009; 6: 292-300
    CrossrefPubMedGoogle Scholar
  • 13 Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 1995; 92: 2540-2549
    CrossrefPubMedGoogle Scholar
  • 14 de Groote P, Helbecque N, Lamblin N, Hermant X, Mc Fadden E, Foucher-Hossein C, Amouyel P, Dallongeville J, Bauters C. Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure. Pharmacogenet Genomics 2005; 15: 137-142
    CrossrefPubMedGoogle Scholar
  • 15 Defoor J, Martens K, Zielinska D, Matthijs G, Van Nerum H, Schepers D, Fagard R, Vanhees L. The Caregene Study: Polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease. Eur Heart J 2006; 27: 808-816
    CrossrefPubMedGoogle Scholar
  • 16 Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, Binder L, Topper A, Lashki DJ, Schwarz S, Herrmann-Lingen C, Loffler M, Hasenfuss G, Halle M, Pieske B. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction results of the ex-dhf (exercise training in diastolic heart failure) pilot study. J Am Coll Cardiol 2011; 58: 1780-1791
    CrossrefPubMedGoogle Scholar
  • 17 El-Armouche A, Eschenhagen T. Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Fail Rev 2009; 14: 225-241
    CrossrefPubMedGoogle Scholar
  • 18 Frey UH, Adamzik M, Kottenberg-Assenmacher E, Jakob H, Manthey I, Broecker-Preuss M, Bergmann L, Heusch G, Siffert W, Peters J, Leineweber K. A novel functional haplotype in the human gnas gene alters galphas expression, responsiveness to beta-adrenoceptor stimulation, and peri-operative cardiac performance. Eur Heart J 2009; 30: 1402-1410
    CrossrefPubMedGoogle Scholar
  • 19 Frey UH, Hauner H, Jockel KH, Manthey I, Brockmeyer N, Siffert W. A novel promoter polymorphism in the human gene gnas affects binding of transcription factor upstream stimulatory factor 1, galphas protein expression and body weight regulation. Pharmacogenet Genomics 2008; 18: 141-151
    CrossrefPubMedGoogle Scholar
  • 20 Giannuzzi P, Temporelli PL, Corra U, Tavazzi L. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: Results of the exercise in left ventricular dysfunction and chronic heart failure (elvd-chf) trial. Circulation 2003; 108: 554-559
    CrossrefPubMedGoogle Scholar
  • 21 Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Larrabee P, Bristow MR. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 1996; 94: 2817-2825
    CrossrefPubMedGoogle Scholar
  • 22 Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, Schoene N, Schuler G. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA 2000; 283: 3095-3101
    CrossrefPubMedGoogle Scholar
  • 23 Harriss DJ, Atkinson G. Update – ethical standards in sport and exercise science research. Int J Sports Med 2011; 32: 819-821
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Huntgeburth M, La Rosee K, ten Freyhaus H, Bohm M, Schnabel P, Hellmich M, Rosenkranz S. The arg389gly beta1-adrenoceptor gene polymorphism influences the acute effects of beta-adrenoceptor blockade on contractility in the human heart. Clin Res Cardiol 2011; 100: 641-647
    CrossrefPubMedGoogle Scholar
  • 25 Ikeda Y, Hoshijima M, Chien KR. Toward biologically targeted therapy of calcium cycling defects in heart failure. Physiology (Bethesda) 2008; 23: 6-16
    CrossrefPubMedGoogle Scholar
  • 26 Jorge Alves A, Ribeiro F, Sagiv M, Eynon N, Yamin C, Oliveira J. Resting measures and physiological responses to exercise for the determination of prognosis in patients with chronic heart failure: Useful tools for clinical decision-making. Cardiol Rev 2010; 18: 171-177
    CrossrefPubMedGoogle Scholar
  • 27 Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994; 90: 234-240
    CrossrefPubMedGoogle Scholar
  • 28 Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction: A randomized, controlled, single-blind trial. Circ Heart Fail 2010; 3: 659-667
    CrossrefPubMedGoogle Scholar
  • 29 Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144-2150
    CrossrefPubMedGoogle Scholar
  • 30 La Rosee K, Huntgeburth M, Rosenkranz S, Bohm M, Schnabel P. The arg389gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines. Pharmacogenetics 2004; 14: 711-716
    CrossrefPubMedGoogle Scholar
  • 31 Liggett SB, Mialet-Perez J, Thaneemit-Chen S, Weber SA, Greene SM, Hodne D, Nelson B, Morrison J, Domanski MJ, Wagoner LE, Abraham WT, Anderson JL, Carlquist JF, Krause-Steinrauf HJ, Lazzeroni LC, Port JD, Lavori PW, Bristow MR. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci USA 2006; 103: 11288-11293
    CrossrefPubMedGoogle Scholar
  • 32 Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a g-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 1999; 274: 12670-12674
    CrossrefPubMedGoogle Scholar
  • 33 Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A, Dorn GW, Liggett SB. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 2003; 9: 1300-1305
    CrossrefPubMedGoogle Scholar
  • 34 Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165-193
    CrossrefPubMedGoogle Scholar
  • 35 Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 1995; 92: 1169-1178
    CrossrefPubMedGoogle Scholar
  • 36 Rathz DA, Gregory KN, Fang Y, Brown KM, Liggett SB. Hierarchy of polymorphic variation and desensitization permutations relative to beta 1- and beta 2-adrenergic receptor signaling. J Biol Chem 2003; 278: 10784-10789
    CrossrefPubMedGoogle Scholar
  • 37 Salazar NC, Chen J, Rockman HA. Cardiac gpcrs: Gpcr signaling in healthy and failing hearts. Biochim Biophys Acta 2007; 1768: 1006-1018
    CrossrefPubMedGoogle Scholar
  • 38 Sandilands AJ, O’Shaughnessy KM, Brown MJ. Greater inotropic and cyclic amp responses evoked by noradrenaline through arg389 beta 1-adrenoceptors versus gly389 beta 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 2003; 138: 386-392
    CrossrefPubMedGoogle Scholar
  • 39 Soares-Miranda L, Franco FG, Roveda F, Martinez DG, Rondon MU, Mota J, Brum PC, Antunes-Correa LM, Nobre TS, Barretto AC, Middlekauff HR, Negrao CE. Effects of exercise training on neurovascular responses during handgrip exercise in heart failure patients. Int J Cardiol 2011; 146: 122-125
    CrossrefPubMedGoogle Scholar
  • 40 Spielmann N, Leon AS, Rao DC, Rice T, Skinner JS, Rankinen T, Bouchard C. Genome-wide linkage scan for submaximal exercise heart rate in the Heritage Family Study. Am J Physiol 2007; 293: H3366-H3371
    PubMedGoogle Scholar
  • 41 Wagoner LE, Craft LL, Zengel P, McGuire N, Rathz DA, Dorn 2nd GW, Liggett SB. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 2002; 144: 840-846
    PubMedGoogle Scholar
  • 42 Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O, Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study. Circulation 2007; 115: 3086-3094
    CrossrefPubMedGoogle Scholar
  • 43 Xiang Y, Kobilka BK. Myocyte adrenoceptor signaling pathways. Science 2003; 300: 1530-1532
    CrossrefPubMedGoogle Scholar
  • 44 Xie HG, Dishy V, Sofowora G, Kim RB, Landau R, Smiley RM, Zhou HH, Wood AJ, Harris P, Stein CM. Arg389gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 2001; 11: 191-197
    CrossrefPubMedGoogle Scholar